These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 9102841

  • 1. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
    Jeremić B, Sibamoto J, Abe M.
    Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
    [Abstract] [Full Text] [Related]

  • 2. Assessment of micronucleus induction in murine SCCVII cells treated with various anticancer agents.
    Jeremic B, Shibamoto Y, Abe M.
    Chemotherapy; 1996; 42(4):266-72. PubMed ID: 8804794
    [Abstract] [Full Text] [Related]

  • 3. Tumor radiosensitivity prediction by the cytokinesis-block micronucleus assay.
    Shibamoto Y, Streffer C, Fuhrmann C, Budach V.
    Radiat Res; 1991 Dec; 128(3):293-300. PubMed ID: 1961926
    [Abstract] [Full Text] [Related]

  • 4. Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome.
    Shibamoto Y, Ike O, Mizuno H, Fukuse T, Hitomi S, Takahashi M.
    Clin Cancer Res; 1998 Mar; 4(3):677-82. PubMed ID: 9533537
    [Abstract] [Full Text] [Related]

  • 5. The radiosensitivity of human malignant melanomas evaluated by cytokinesis-block micronucleus assay.
    Wideł M, Dobrut M, Maka B, Lubecka B, Pluciennik A.
    Neoplasma; 1997 Mar; 44(2):109-16. PubMed ID: 9201290
    [Abstract] [Full Text] [Related]

  • 6. The increment of micronucleus frequency in cervical carcinoma during irradiation in vivo and its prognostic value for tumour radiocurability.
    Widel M, Jedruś S, Owczarek S, Konopacka M, Lubecka B, Kołosza Z.
    Br J Cancer; 1999 Jul; 80(10):1599-607. PubMed ID: 10408406
    [Abstract] [Full Text] [Related]

  • 7. Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors.
    Masunaga S, Ono K, Akaboshi M, Takagaki M, Kinashi Y, Suzuki M, Abe M.
    Radiat Med; 1997 Jul; 15(1):37-43. PubMed ID: 9134583
    [Abstract] [Full Text] [Related]

  • 8. Micronucleus assay prediction and application optimized by cytochalasin B-induced binucleated tumor cells.
    Fuhrmann C, Streffer C, Müller WU, Becker U.
    Strahlenther Onkol; 1992 Oct; 168(10):603-9. PubMed ID: 1440232
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S, Ono K, Hori H, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Kasai S, Nagasawa H, Uto Y.
    Radiat Med; 1998 Oct; 16(6):441-8. PubMed ID: 9929144
    [Abstract] [Full Text] [Related]

  • 10. In vitro micronucleus technique to predict chemosensitivity.
    Fenech M.
    Methods Mol Med; 2005 Oct; 111():3-32. PubMed ID: 15911968
    [Abstract] [Full Text] [Related]

  • 11. Correlation of radiation-induced micronucleus frequency with clonogenic survival in cells of one diploid and two tetraploid murine tumor cell lines of the same origin.
    Mariya Y, Streffer C, Fuhrmann C, Wojcik A.
    Radiat Res; 1997 Jan; 147(1):29-34. PubMed ID: 8989366
    [Abstract] [Full Text] [Related]

  • 12. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay.
    Nio Y, Tamura K, Kan N, Inamoto T, Ohgaki K, Kodama H.
    Anticancer Res; 2000 Jan; 20(2B):1237-44. PubMed ID: 10810427
    [Abstract] [Full Text] [Related]

  • 13. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S, Sakurai Y, Suzuki M, Nagata K, Maruhashi A, Kinash Y, Ono K.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):920-7. PubMed ID: 15465210
    [Abstract] [Full Text] [Related]

  • 14. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
    Masunaga S, Ono K, Hori H, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y.
    Radiat Med; 1999 Nov 01; 17(4):259-64. PubMed ID: 10510897
    [Abstract] [Full Text] [Related]

  • 15. Anticancer Drug Development: The Way Forward.
    Connors T.
    Oncologist; 1996 Nov 01; 1(3):180-181. PubMed ID: 10387985
    [Abstract] [Full Text] [Related]

  • 16. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A, Rommel F, Breise M, Willers R, Göbel U, Wessalowski R.
    Klin Padiatr; 2002 Nov 01; 214(4):223-9. PubMed ID: 12165906
    [Abstract] [Full Text] [Related]

  • 17. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y, Li JD, Shi HL, Liu JH, Feng YL, Li MD.
    Ai Zheng; 2007 Apr 01; 26(4):386-9. PubMed ID: 17430657
    [Abstract] [Full Text] [Related]

  • 18. Estimation of the initial slope of the cell survival curve after irradiation from micronucleus frequency in cytokinesis-blocked cells.
    Ono K, Masunaga S, Akaboshi M, Akuta K.
    Radiat Res; 1994 Apr 01; 138(1 Suppl):S101-4. PubMed ID: 8146309
    [Abstract] [Full Text] [Related]

  • 19. [Prediction of radiosensitivity by micronucleus assay].
    Ono K.
    Gan No Rinsho; 1989 Oct 01; 35(13):1566-71. PubMed ID: 2585727
    [Abstract] [Full Text] [Related]

  • 20. Carboplatin-induced micronuclei formation in non-neuronal cells of rat foetal dorsal root ganglia cultured in vitro and comparison with another anticancer drug--cisplatin.
    Jirsová K, Mandys V.
    Sb Lek; 1996 Oct 01; 97(3):331-42. PubMed ID: 9174376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.